Pages that link to "Q34658528"

The following pages link to Fibrosis and carcinoid syndrome: from causation to future therapy (Q34658528):

Displaying 38 items.

• Complications from carcinoid syndrome: review of the current evidence (Q28068096) (← links)
• The biological hallmarks of ileal carcinoids (Q28238359) (← links)
• Identification of a Novel Allosteric Inhibitory Site on Tryptophan Hydroxylase 1 Enabling Unprecedented Selectivity Over all Related Hydroxylases (Q33639498) (← links)
• VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis (Q33926020) (← links)
• Pancreatic duct stenosis secondary to small endocrine neoplasms: a manifestation of serotonin production? (Q34138747) (← links)
• Serotonin receptors and heart valve disease--it was meant 2B. (Q34173511) (← links)
• Neuroendocrine tumors of the small bowels are on the rise: Early aspects and management (Q34389590) (← links)
• Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide (Q34428697) (← links)
• Cadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour (Q34995751) (← links)
• Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis. (Q35650633) (← links)
• Malignant tumours of the small intestine: a review of histopathology, multidetector CT and MRI aspects. (Q36323900) (← links)
• Use of antidepressant serotoninergic medications and cardiac valvulopathy: a nested case-control study in the health improvement network (THIN) database (Q36336069) (← links)
• Rectal Mechano-sensory Function in Patients with Carcinoid Diarrhea (Q36762652) (← links)
• A case of carcinoid likely causing jejunal intussusception. (Q37686608) (← links)
• Neuroendocrine Tumor (Carcinoid) Metastatic to Orbital Extraocular Muscle: Case Report and Literature Review (Q37810998) (← links)
• Recent advances in the diagnosis and treatment of gastrointestinal carcinoids (Q37939889) (← links)
• ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas (Q37977337) (← links)
• Profiling of ileal carcinoids (Q38044219) (← links)
• Current concepts in diagnosis and perioperative management of carcinoid heart disease. (Q38061530) (← links)
• Targeting the somatostatin receptor in pituitary and neuroendocrine tumors (Q38132768) (← links)
• Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies (Q38956091) (← links)
• Telotristat ethyl: a new option for the management of carcinoid syndrome. (Q39000212) (← links)
• Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model (Q39461570) (← links)
• Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome (Q45156763) (← links)
• Neuroendocrine tumors and fibrosis: An unsolved mystery? (Q47720153) (← links)
• Telotristat ethyl: a novel agent for the therapy of carcinoid syndrome diarrhea. (Q47724043) (← links)
• The use of antidepressants and the risk of chronic atrial fibrillation. (Q47785027) (← links)
• Metastatic small bowel neuroendocrine tumour with bilateral carcinoid heart disease (Q47891547) (← links)
• Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial (Q50059510) (← links)
• Carcinoid-syndrome: recent advances, current status and controversies (Q50094023) (← links)
• Flushing Disorders Associated with Gastrointestinal Symptoms: Part 1, Neuroendocrine Tumors, Mast Cell Disorders and Hyperbasophila. (Q52719735) (← links)
• Echocardiography in functional midgut neuroendocrine tumors: When and how often. (Q52865572) (← links)
• Stenting of the superior mesenteric vein in midgut carcinoid disease with large mesenteric masses. (Q53315228) (← links)
• The expression of the hypoxia markers CA9 and CXCR4 is correlated with survival in patients with neuroendocrine tumours of the ileum (Q57118789) (← links)
• New Developments in the Treatment of Neuroendocrine Tumours - RADIANT-4, NETTER-1 and Telotristat Etiprate (Q88312414) (← links)
• Assessment of Peripheral Serotonin Synthesis Using Stable Isotope-Labeled Tryptophan (Q88381221) (← links)
• Workup of Gastroenteropancreatic Neuroendocrine Tumors (Q90164667) (← links)
• Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes (Q93185519) (← links)